Although several reports demonstrated that IGF-1 can enhance MMP activity in both ER positive [25], [26] and ER negative [60] breast cancer cells, we did not observe any increase in general MMP activity with either pII or YS1.2 cells treated with IGF-1 at similar dose range used in these studies. The gene discussed is ESR1; the disease is breast carcinoma.